Cepheid Logo
Request Info
Location / Language

{{headingText}}

{{paragraphText}}

{{continueBtnLabel}}
{{initials}}
Main Menu
Location / Language

{{headingText}}

{{paragraphText}}

{{continueBtnLabel}}

Request Info
Request Info
Community Global Health Light Hero Notxt image
Cepheid

Cepheid

Editorial Team

5m Read

March 27, 2026

COMMUNITY AND GLOBAL HEALTH

Article

Hepatitis C Elimination in the U.S. is Within Reach, Experts Report

Hepatitis C elimination in the U.S. is within reach—if we do three things: expand point‑of‑care testing, scale treatment access, and unify stakeholders for coordinated action, according to health economists Louis Garrison, Ph.D. and Bruce Wang, Ph.D. 

 

In a Viewpoint paper in JAMA Health Forum, the economists detail progress toward HCV elimination, including why "single-step HCV diagnosis is widely seen as a critical component of an HCV elimination program"1 and why U.S. policy makers should support the Cure Hepatitis C Act of 2025 (S.1941).

 

At Cepheid, we’re proud to support HCV elimination efforts by offering the Xpert® HCV test, which provides point‑of‑care molecular detection to help expand access to diagnosis.

 

Read the full paper JAMA Health Forum.

Image of the Viewpoint paper

IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.

 

1 Garrison LP, Wang BCM. Stakeholder Engagement for Hepatitis C Virus Elimination. JAMA Health Forum. 2026;7(1):e256433. doi:10.1001/jamahealthforum.2025.6433

Was this article helpful?

Read Next

MORE